Plasma Lipids and Lipoproteins in Sickle Cell Disease Patients in the Northern West Bank, Palestine

Table 2

Hematological parameters of SCD patients and controls. Data are expressed as . Mean comparison has been performed separately between the gender groups in patients and controls.

Group		Age (y)	Hb (g/dL)	RBC (×10^12/L)	MCV (fL)	value
Sickle cell anemia (SS)
Females	32		^a,b	^a,b,c	^a,b,c	<0.001
Males	30		^a,b	^a,b,c	^a,b,c
Subtotal	62
Sickle β-thalassemia (ST)
Females	21		^a,b	^a,b	^a,b	<0.001
Males	33		^a,b	^a,b	^a,b
Subtotal	54
Sickle cell trait (AS)
Females	14					<0.05
Males	21		^b	^d
Subtotal	35
Controls (AA)
Females	71
Males	89
Subtotal	160
Total	311

Statistically significant at value < 0.001 compared to ^aAS, ^bAA, and ^cST or at value < 0.05 compared to ^dAA and ^eST.